LGM Pharma Announces New CEO

LGM Pharma Announces New CEO

LGM Pharma Announces New CEO
Press Release

ERLANGER, Kentucky / Boca Raton, Florida—LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New York and Israel recently announced that Dr. Prasad S. Raje, Ph.D. would be joining the organization as the company CEO.

In that capacity, Dr. Raje will be heading up all company management activities as well as implementing various growth strategies for the company and will be working out of LGM’s business offices, based in Boca Raton, Florida. LGM co-founders Gideon Schurder, Commercial Director, and Mendy Schurder, COO, will continue in their roles, working closely with Dr. Raje to execute the growth strategy of the company. Following the growth capital investment by New Harbor Capital in 2017, the addition of Dr. Raje as CEO is a key element of the company’s investment in its operational infrastructure through key additions to its senior management team, strategic acquisitions, and integration of sophisticated technologies and intelligence platforms, all with the aim of expanding LGM’s market presence and capabilities to better serve the pharmaceutical industry.

According to Gideon Schurder, “Dr. Raje has technical and executive management expertise spanning contract chemistry, contract analytical testing, and GMP manufacturing of small and large molecules. He has deep understanding of contract pharma industry dynamics and growth opportunities to drive strategic growth plans.” Jocelyn Stanley, Partner at New Harbor Capital, added: “We are excited to have Dr. Raje join the LGM team. His deep pharma experience and keen business sense will add significant value as LGM executes its aggressive growth strategy.”

Dr. Raje brings with him a wealth of experience and business knowledge in the pharmaceutical industry. Prior to joining LGM Pharma, Dr. Raje was President and CEO at Nanotherapeutics as the company transformed from product development to a biologics-based CDMO. Prior to that, Dr. Raje led the Life Sciences Division of EAG Laboratories, a global CRO specializing in analytical and toxicology services. Dr. Raje created the Life Sciences Division, overseeing four global sites and approximately 700+ employees, helping to drive top-line growth, through both organic and acquisition initiatives.

Dr. Raje has previously held leadership roles at Cambridge Major Laboratories, Smithers Pharma Services, Albany Molecular Research (AMRI), and Abbott Labs. Dr. Raje holds both a Bachelor of Science in Chemistry and a Master of Science in Industrial Chemistry from Gujarat University, Gujarat, India, and earned his Ph.D. in Organic Chemistry from Auburn University in Auburn, Alabama.

About LGM Pharma
LGM Pharma is an innovation-driven API company, involved in distribution of quality cGMP pharma ingredients to leading pharmaceutical companies. LGM specializes in streamlining the API supply chain management throughout all development and commercial stages while providing complete technical capabilities, expert regulatory support as well as other value-added services.

  • Share:

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service